That is where most of the dropouts happen, and where insight has to turn into action
Phase 2 trials showed people losing up to 10.8% of body weight with cagrilintide alone - and that's without combining it with other medications
Common adverse effects of GLP-1 medications include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation, particularly when initiating treatment or increasing doses
The injections can provide numerous benefits, including increased energy levels, improved mood, enhanced cognitive function, and a strengthened immune system
Healthcare professionals should approach disclosures of combined peptide use with a non-judgemental but clinically thorough assessment, and provide harm-minimisation advice where appropriate
During the off-cycle, transitioning to mechanistically distinct compounds like MK-677 maintains anabolic signalling through different pathways while IGF-1 receptors recover